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Abstract
During rat estrous cycle, the endometrium proliferates in response to sex steroids and specific
endometrial epithelial cells undergo apoptosis in absence of embryonic factors. The central
executioner of apoptosis is a family of aspartic acid-specific cysteine proteases known as caspases.
Smac/DIABLO is released from the mitochondria during apoptosis and its stimulation promotes
caspases activation by neutralizing members of the inhibitor of apoptosis proteins (IAPs) family,
such as X-linked inhibitor of apoptosis protein (XIAP). The aim of this study was to investigate the
involvement of Smac/DIABLO and XIAP in the control of caspases activation in endometrium of
cycling rats. Polyoestrus female rats were sacrificed at each stage of estrous cycle (diestrus,
proestrus, estrus, and metestrus). Endometrial protein extracts were collected to perform
Western Blot analysis. Alternatively, uterine horns were sectioned for immunohistochemistry
(IHC). We and others showed previously the presence of apoptosis at estrus in rat uterine
epithelium. In the present study, cleaved caspase-3, -6, and -7 fragments were detected at estrus.
IHC confirmed that caspase-3 was present only in luminal and glandular epithelium at estrus. XIAP
was highly expressed at estrus in both epithelial and stromal cells. In contrast, expression of Smac/
DIABLO was elevated at diestrus, proestrus and metestrus but was minimal at estrus. Treatment
of ovariectomized rats with 17β-estradiol induced XIAP expression and inhibited Smac/DIABLO
protein expression in the endometrium. Cleaved caspase-3, -6, and -7 fragments increased in
endometrial protein extracts following 17β-estradiol treatment. Expression of NF-κB and IκB
proteins, and IκB phosphorylation status were detected in the endometrium but were not
influenced by the estrous cycle. These findings suggest that Smac/DIABLO and XIAP are regulated
differently and may play important roles in the regulation of endometrial cell fate. Moreover, this
study confirms a key role for executioner caspases in the control of apoptotic processes at estrus
in the rat uterus.
Introduction
In the absence of embryonic factors during pre-implanta-
tion period in uterine luminal epithelium, glands and
stroma cell death is found in a cycling fashion through the
estrous cycle by a mechanism known as apoptosis. Estro-
gens and progesterone are directly responsible for the his-
tological and morphogical changes in the uterus during
estrous cycle. Studies have shown that apoptosis was
induced in luminal epithelium at estrus in mouse [1] and
rat [2,3]. Other studies have shown that estrogen induces
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uterine epithelial cell proliferation and estrogen with-
drawal results in cell death [4–6]. However, little is known
about the cellular and molecular mechanisms involved in
the regulation of apoptosis in the uterus. Our group has
recently demonstrated that Akt, a serine/threonine pro-
tein kinase also known as PKB, is an important kinase
involved in the control of endometrial cell proliferation
and its expression and phosphorylation/activation are
regulated during the estrous cycle, particularly through
the action of 17β-estradiol [7]. We have further showed a
decrease in Akt activity at estrus which was accompanied
by an increase in apoptosis in luminal epithelial cells[7].
Whether downstream Akt targets might be involved in the
regulation of proliferation/cell death in the endometrium
is unknown.
X-linked inhibitor of apoptosis protein (XIAP) is a well
known inhibitor of caspase-3, -7 and -9 [8,9]. XIAP
belongs to a family of IAP genes which represent critical
regulatory factors of apoptosis signaling and regulation.
The IAP family also includes c-IAP1 (HIAP2), c-IAP2
(HIAP1), NAIP and Survivin [10]. Recently, we demon-
strated in rat granulosa cells and human ovarian surface
epithelial cancer cells that XIAP overexpression induces
Akt phosphorylation/activation [11,12]. Akt is activated
by phosphorylation at threonine 308 and serine 473 in
response to growth factors or cytokines [13–15] through
phosphatidylinositol 3-kinase (PI 3-K). Once phosphor-
ylated Akt has been shown to 1) phosphorylates and
blocks the action of several pro-apoptotic proteins such as
Bad [14], and 2) block cytochrome C release from the
mitochondria through the regulation of Bcl-2 [16]. The
kinase Akt has been shown to induces phosphorylation of
procaspase-9, suggesting that caspase processing and
apoptosis can be directly regulated by protein phosphor-
ylation [17]. This is supported by the observation that an
activated form of Akt is able to block apoptosis [18].
At the time of apoptosis induction Smac/DIABLO is
released from mitochondria into the cytosol, where it
binds to IAPs and enables caspase activation [19]. It has
been shown that Smac/DIABLO promotes not only the
proteolytic activation of procaspase-3 but also the enzy-
matic activity of mature caspase-3, both of which depend
upon its ability to interact physically with IAPs [19].
Smac/DIABLO is synthesized with an N-terminal mito-
chondrial targeting sequence that is proteolytically
removed during maturation to the mature polypeptide. X-
ray crystallography has shown that the first four amino
acids (AVPI) of mature Smac/DIABLO bind to a portion of
the third BIR (BIR3) domain of XIAP [20]. This N-termi-
nal sequence is essential for binding IAPs and blocking
their antiapoptotic effects [20].
Caspases are well known executioners of apoptosis. Once
activated from their proactive forms, caspases target
important proteins involved in cell proliferation and sur-
vival (for a review see [21]). Caspase-3 is one of the key
executioner of apoptosis and induces downstream cas-
pase-6 which in turn target cleavage of important struc-
tural proteins such as laminin and keratins [22,23].
Among other caspase targets, poly(ADP-ribose) polymer-
ase (PARP, 113–116 kDa), a nuclear enzyme which is acti-
vated during DNA damage, is known to be cleaved by
caspases-3 and -7 [24]. We have recently demonstrated
that Akt is also a target for caspase-3 cleavage, indicating
that Akt survival pathway inhibition is an important
mechanism for apoptosis activation [12].
Although the regulation and importance of XIAP and
Smac/DIABLO has been described in other systems and
cell types, their expression has not been reported for the
uterus. In the present study, we have investigated the reg-
ulation of XIAP, Smac/DIABLO, caspase-3, -6 and -7 dur-
ing the four stages of estrous cycle (proestrus, estrus,
metestrus and diestrus) and further analyses were carried
out to determine the possible regulation of XIAP and
Smac/DIABLO by 17β-estradiol in ovariectomized rats.
Materials and Methods
Reagents
XIAP, Smac/DIABLO, NF-κB, IκB, Phospho-IκB and
cleaved-caspases antibodies were obtained from New
England Biolabs (Mississauga, ON). Vectastain ABC Kit
for rabbit IgG was purchased from Vector Laboratories
Inc. (Burlingame, CA). Protease Inhibitor Cocktail Tab-
lets, POD and DAB substrate were purchased from Roche
(Laval, QC). 17β-estradiol (E2) was purchased from Labo-
ratoire Mat (Québec, QC).
Animals
Mature Sprague-Dawley female rats (200–225 g) were
obtained from Charles River Laboratories Canada. Ani-
mals were maintained on standard chow and water,
which were available ad libitum, in animal facilities illumi-
nated on a normal 12 hour cycle. All procedures were per-
formed in accordance with guidelines of the Canadian
Council on Animal Care for the handling and training of
laboratory animals and the Good Health and Animal Care
Committee of the Université du Québec à Trois-Rivières.
Stages of the estrous cycle were confirmed by vaginal
smears. Rats with three regular cycles of 4 days were used
in these experiments and killed at various stages of the
estrous cycle (diestrus, proestrus, estrus and metestrus).
Uteri were collected and fixed for immunohistochemical
staining (IHC) or endometrial protein extracts collected
by scraping the endometrium for Western analysis. To
determine the effect of estrogen, rats were ovariectomized
for at least 10 days and then injected with (17β-estradiol)Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/59
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E2. Animals were treated for a total of 3 days and killed
after hormone treatment (72 hours) according to previous
preliminary time-course studies done in our laboratory
(Leblanc et al., unpublished information) and informa-
tion found in the literature [25]. E2 was dissolved with ses-
ame oil, and administered by subcutaneous injection.
Sesame oil was injected into control animals. The dose
administered was 40 µg/kg/day (E2).
Immunohistochemistry
The uterus was fixed in 4% paraformaldehyde solution
and embedded in paraffin. Tissue sections 7 µm thick
were mounted on polylysine-coated slides, deparaffin-
ized, rehydrated, and then heated with 10 mM citrate
buffer (pH 6). After two wash with PBS, slides were then
incubated with 0.3 % hydrogen peroxide in methanol for
30 min to quench endogenous peroxidase activity. After
washing with PBS, tissues were incubated with blocking
serum (Vectastain ABC Kit) at room temperature for 1 h.
Then, a primary antibody (XIAP 1:200; Smac/DIABLO
1:100; and cleaved caspase-3 1:100) was added to the
slides and incubated at 4°C overnight. After washing 5
min in PBS, tissue sections were incubated for 30 min
with 3 µg/ml biotinylated antibody (anti-rabbit or anti-
mouse). Subsequently, slides were washed with PBS and
incubated with avidin-biotin complex reagent containing
horseradish peroxidase for 30 min. Again washed with
PBS for 5 min and colour development was achieved
using DAB substrate. The tissue sections were counter-
stained with haematoxylin. Negative controls were per-
formed using the same protocol without the presence of
primary antibody.
Protein extraction and Western analysis
Endometrium from each uterus was scraped using a glass
microscope slide and homogenized using a pipette in the
lysis buffer (PBS 1X pH 7.4; 1% Nonidet P-40; 0.5%
Sodium deoxycholate; 0.1% SDS; Protease Inhibitor
Cocktail Tablets (Roche)). Homogenates were centrifuged
(12,000 × g for 20 min at 4°C) to remove insoluble mate-
rial. The supernatant was recovered and stored at -20°C
pending analysis. Protein content was determined with
the Bio-Rad DC Protein Assay. Concentrations of reagents
found in the lysis buffer were chosen to avoid any interfer-
ence with the protein assay. Protein extracts (50 µg) were
heated at 94°C for 3 min, resolved by 10% SDS-PAGE and
electrotransferred to nitrocellulose membranes using a
semidry transfer (Bio-Rad, Mississauga, ON). The mem-
branes were then blocked 2 h at room temperature with
PBS containing 5 % milk powder, then incubated with
XIAP 1:500; Smac/DIABLO 1:500; Caspase-3 1:1000; Cas-
pase-6 1:1000; Caspase-7 1:1000; NF-κB 1:1000; IκB
1:1000; Phospho-IκB 1:500 and subsequently with horse-
radish peroxidase-conjugated anti-rabbit or anti-mouse
secondary antibody (1:3000; room temperature for 45
min). All membranes were reprobed with a antibody spe-
cific to β-actin which was used as an internal standard.
Densitometrical analyses were performed on both films
(protein of interest and β-actin) using the GelDoc 2000
and the Quantity One software (Bio-Rad, Mississauga,
ON). Results are expressed as a ratio protein of interest/β-
actin to correct for loading for each endometrial sample.
Statistical analysis
Western analyses of cycling animals were repeated four to
six times (one rat per extract/day repeated 4 to 6 different
times). Endometrial extracts from each rats was assessed
individually. Western blot analyses were performed with
samples from ovariectomized rats treated with E2 (4 rats/
group). Endometrial extracts from each rats was assessed
individually for both studies. Results subjected to statisti-
cal analyses were expressed as means ± SEM. Data were
subjected to one-way ANOVA (PRISM software version
4.0; GraphPad, San Diego, CA). Differences between
experimental groups were determined by the Tukey's test.
Statistical significance was accepted when P < 0.05.
Results
Caspases activation during the estrous cycle
We have shown previously that apoptosis was maximal at
estrus and weakly detectable at metestrus, diestrus and
proestrus [7]. Apoptosis was mainly located in luminal
epithelial cells at estrus. On the other hand, cell prolifera-
tion was maximal at proestrus as determined by expres-
sion of the cell proliferation marker CDC47/MCM7 [7].
Since executioner caspases such as caspase-3, -6 and -7 are
key proteases involved in the execution of apoptosis, we
have investigated, using antibodies specific for activated
forms (cleaved fragments), their expression in the
endometrium throughout estrous cycle. Caspase-3 frag-
ments were detected in greatest amounts at estrus (Fig. 1).
Caspase-3 19 KDa fragment was weakly detectable at die-
strus and proestrus, maximal at estrus and further reduced
at metestrus. Likewise, caspase-3 17 KDa fragment was
detected only at estrus and metestrus but was significantly
reduced at metestrus compared to estrus. Large cleaved
caspase-6 subunit (18 KDa) was absent at diestrus and
proestrus, maximal at estrus and reduced at metestrus.
Similarly, large cleaved caspase-7 subunit (19 KDa) was
weakly detected at diestrus and proestrus, was highly
increased at estrus and reduced at metestrus. IHC studies
using the antibody specific for cleaved caspase-3 (cleaved
caspase-6 and -7 antibodies are not functional for IHC)
revealed that cleaved caspase-3 fragment signal was
located in apoptotic luminal epithelial cells at estrus and
that the signal was absent in proliferative endometrium at
proestrus.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/59
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Cleaved caspase-3, -6, and -7 expression in rat endometrium during estrous cycle Figure 1
Cleaved caspase-3, -6, and -7 expression in rat endometrium during estrous cycle. Polyoestrus rats were sacrificed at each 
stage of the estrous cycle (diestrus, proestrus, estrus and metestrus) and total endometrial proteins were collected. A) West-
ern blots of cleaved caspase-3, -6 and -7 (one blot presented out of 4). Graphics shows Western blots densitometric analysis. 
Data represent the mean ± SEM of four independent experiments (four different rats). B) Immunohistochemistry of cleaved 
caspase-3. IHC shown are from one representative experiment (a total of four different uterine sections from four different 
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XIAP and Smac/DIABLO expression during the estrous 
cycle
Expression of XIAP and Smac/DIABLO proteins has not
been reported for the uterus. Because we have demon-
strated previously a possible link between XIAP and sur-
vival factor Akt [11,12] and further that Akt expression
and activity/phosphorylation are regulated by 17β-estra-
diol in rat endometrium [7], we have asked the question
whether XIAP and its inhibitor Smac/DIABLO might have
important roles in the control of endometrial cell fate.
Western blot revealed that XIAP protein was present at all
stages of the estrous cycle, but maximal at estrus (Fig. 2;
2.9-fold increase compared to proestrus; p < 0.05). IHC
revealed that XIAP expression was high in stromal cells
and in both luminal and glandular epithelial cells at
estrus (Fig. 3). Expression of Smac/DIABLO during
estrous cycle was similar at metestrus, diestrus and proe-
strus but was significantly reduced at estrus (Fig. 2; 3.6-
fold decrease compared to proestrus; p < 0.05). IHC con-
firmed downregulation of Smac/DIABLO at estrus and
showed that it was localized mainly in epithelial cells but
was also present in stromal cells (Fig. 3).
Effect of 17β-estradiol on XIAP and Smac/DIABLO 
expression and caspases activation
To further determine importance of 17β-estradiol in the
regulation of XIAP and Smac/DIABLO, ovariectomized
rats were treated with 17β-estradiol and uteri were recov-
ered for Western analysis (Fig. 4) and IHC (Fig. 5) analy-
ses. Our previous results indicated that 17β-estradiol
increased significantly endometrial cell proliferation (as
determined by the expression of CDC47/MCM7) and
increased Akt protein expression and its phosphorylation/
activity [7]. In the present study, results shows that 17β-
estradiol induced significantly XIAP protein expression
(4.0-fold compared to control; p < 0.05) whereas it signif-
icantly inhibited Smac/DIABLO protein expression (2.7-
fold compared to control; p < 0.05) (Fig. 4). IHC analysis
in ovariectomized rats confirmed the increase of XIAP
expression and inhibition of Smac/DIABLO in the
endometrium (Fig. 5). As observed during estrous cycle
Smac/DIABLO and XIAP expression in rat endometrium during estrous cycle Figure 2
Smac/DIABLO and XIAP expression in rat endometrium during estrous cycle. Total endometrial proteins were collected from 
polyoestrus cycling rats at each stage of the estrous cycle (diestrus, proestrus, estrus and metestrus). A) Western blots analy-
ses of Smac/DIABLO and XIAP (one blot presented out of 6). Graphics shows Western blots densitometric analysis. Data rep-
resent the mean ± SEM of four independent experiments (four different rats). *Significantly different from all other days of 
estrus cycle (p < 0.05).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/59
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Immunohistochemistry of Smac/DIABLO and XIAP in rat endometrium during estrous cycle Figure 3
Immunohistochemistry of Smac/DIABLO and XIAP in rat endometrium during estrous cycle. IHC shown are from one repre-
sentative experiment carried out on four different uterine sections (a total of four different uterine sections from four different 
rats per day of the estrous cycle have been tested). Negative control: primary antibody absent.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/59
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Expression of cleaved caspase-3, -6, -7, Smac/DIABLO and XIAP in response to 17β-estradiol (E2) in ovariectomized rats Figure 4
Expression of cleaved caspase-3, -6, -7, Smac/DIABLO and XIAP in response to 17β-estradiol (E2) in ovariectomized rats. Ova-
riectomized rats received daily subcutanous injections of E2 (40 µg/Kg/day) or vehicle for control group for 3 days. Graphics 
shows Western blots (one blot presented out of 4) densitometric analysis. Data represent the mean ± SEM of four independ-
ent experiments (4 rats per group). *Significantly different from control (p < 0.05).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/59
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(Fig. 3), XIAP and Smac/DIABLO proteins were found
mainly in epithelial cells but were also present in stroma
(Fig. 5). The effect of 17β-estradiol on the regulation of
XIAP and Smac/DIABLO support the mitogenic role of
17β-estradiol and its involvement in cell survival.
Immunohistochemistry of Smac/DIABLO and XIAP in rat endometrium of treated ovariectomized rats Figure 5
Immunohistochemistry of Smac/DIABLO and XIAP in rat endometrium of treated ovariectomized rats. Ovariectomized rats 
received daily subcutanous injections of E2 (40 µg/Kg/day) or vehicle for control group for 3 days. IHC shown are from one 
representative experiment per group (a total of four different uterine sections from four different treated ovariectomized rats 
have been tested).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/59
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NF-κB pathway regulation through the estrous cycle
The NF-κB pathway has been shown to be activated by Akt
in several cell types (for a review [26]). Furthermore, it has
been shown that XIAP expression is up-regulated once NF-
κB is activated and translocated to the nucleus [27,28].
The activation of NF-κB proceeds through the phosphor-
ylation of its inhibitor, IκBα, that targets it for polyubiq-
uitination and subsequent enzymatic degradation by the
26S ubiquitin proteasome [29]. Since we have showed an
increase of Akt phosphorylation in response to E2 [7], we
sought to determine if NF-κB/IκB pathway might be
involved in the regulation of XIAP expression in response
to 17β-estradiol. The present study shows that NF-κB
(both p50 and p65 subunits) and IκB proteins were both
expressed in the endometrium but were not influenced by
the estrous cycle (Fig. 6). Since IκB phosphorylation status
is a sign of NF-κB activation, we also carried out Western
analyses using a phospho specific IκB antibody (Fig. 6C).
The results showed that phosphorylation of IκB was
detected at all days of estrous cycle but was not influenced
by the estrous cycle. These results demonstrate that NF-
κB/IκB pathway is not involved in the regulation of XIAP
expression in the cycling rat uterus.
Discussion
We and other have demonstrated the presence of apopto-
sis in the rat [2,3,7] and mouse [1] endometrium during
the estrous cycle. Although our recent study showed that
regulation of Akt survival pathway is a key factor involved
in the regulation of endometrial cell fate during estrous
cycle [7], molecular and cellular mechanisms involved in
the regulation of apoptosis in the uterus are poorly docu-
mented in the literature. Since menses are absent in
rodent specie, there must be precise intra-cellular mecha-
nisms involved in the regulation of cell fate in the
endometrium after estrogen withdrawal in the absence of
embryonic factors. We have previously demonstrated in
human ovarian cancer cells [12] and rat granulosa cells
[11] the importance of XIAP and Akt expression/activity.
In the present study, regulation of XIAP and Smac/DIA-
BLO have been investigated in rat uterus to determine
their importance and their possible influence on endome-
trial cell survival/death in relation to the stage of estrous
cycle.
In the present study, expression of XIAP was maximum at
estrus and increased in response to E2 in ovariectomized
rats. XIAP was strongly expressed in luminal and glandu-
lar epithelia and stroma during estrus, perhaps to protect
these cells from apoptosis. Although stimulation of XIAP
by E2 is consistent with mitogenic activity and apoptosis
inhibitory activity, it is not clear why XIAP expression
does not increase during proestrus. A recent study showed
that XIAP may be directly regulated by the presence of
tumor necrosis factor-α (TNF-α) in rat granulosa cells
[27]. Since it has been shown that TNF-α mRNA expres-
sion was high at estrus and was regulated by estrogen in
the mouse uterus [30], a similar process may be involved
in the endometrium. Thus, action of E2  on XIAP
expression might be indirect and might involve specific
factors regulated upstream and/or downstream by this
hormone. Whether involvement of TNF-α or other growth
factors/cytokines might be involved in this process
remains to be elucidated.
In contrast, Smac/DIABLO was decreased at estrus and E2
treatment in ovariectomized rats reduced its expression.
These results directly support the mitogenic action of
estrogens on endometrial cells. Since Smac/DIABLO is a
pro-apoptotic protein, its down-regulation may be suffi-
cient to activate XIAP to inhibit caspase activity. Smac/
DIABLO down-regulation also support our results
obtained at estrus showing apoptosis predominantly in
luminal epithelial cells [7] and suggest that this pro-apop-
totic factor might have a key function in triggering apop-
tosis at this particular time of rat estrous cycle. There is
currently no information available in the literature dem-
onstrating that E2 modulates Smac/DIABLO expression
and the present findings are the first to demonstrate this
mechanism. E2treatment resulted in the cleavage of cas-
pase-3, -6 and -7 in endometrial cells. This results was
contradictory to the fact that E2 induces endometrial cells
proliferation rather than inducing activation of the cas-
pase cascade and apoptosis. Although it has been shown
that E2triggers apoptosis in a preosteoclastic cell line in
vitro [31] and in thymocytes of ovariectomized mice in
vivo [32], it is unlikely that E2 induced apoptosis in the
endometrium. This can be explained by the fact that
following injection of ovariectomized rats with E2, latent
endometrial cells are forced to proliferate and they might
be in a situation of stress. Indeed, controlling the balance
between survival and death factors is a key mechanism in
order to maintain homeostasis in the proliferating
endometrium. Increased caspase cleavage is not necessar-
ily a sign of apoptosis activation; caspases activity can be
blocked by the presence of high levels of XIAP (or other
known or unknown inhibitor of apoptosis proteins such
as cIAPs [33]) and the presence of low levels of Smac/DIA-
BLO. This particular mechanism in endometrial cells
might be important in order to rapidly induce apoptosis
at the appropriate timing (at estrus for instance) through
the simple inhibition or degradation of XIAP protein
through its ubiquitin protein ligase activity its degrada-
tion in proteasomes in response to apoptotic stimuli [34].
Another explanation for the induction of caspase activa-
tion in response to E2 might be due to the presence and
activity of E2 metabolites. For example, 2-Methoxyestra-
diol (2ME2), a natural metabolite of E2, is a potent antitu-
mor and antiangiogenic agent [35] and has been shown toReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/59
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NF-κB, IκB and phospho-IκB expression in rat endometrium during estrous cycle Figure 6
NF-κB, IκB and phospho-IκB expression in rat endometrium during estrous cycle. Total endometrial proteins were collected 
from polyoestrus cycling rats at each stage of the estrous cycle (diestrus, proestrus, estrus and metestrus). A) Western blots 
analyses of NF-κB, IκB and phospho-IκB (one blot presented out of 6). Graphics shows Western blots densitometric analysis. 
Data represent the mean ± SEM of six independent experiments (six different rats)
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induce apoptosis is several cell type (for a review see [36]).
Furthermore, 2ME2 is currently tested in clinical trials for
cancer therapies [36]. 2ME2 is a major metabolite of estra-
diol in human serum and its concentration peaks at mid-
cycle, like that of estradiol [37]. Studies have shown that
2ME2 acts through other signaling pathways than
E2[38,39]. A recent study revealed that 2ME2 treatment
resulted in up-regulation of death receptor 5 (DR5) pro-
tein expression in vitro and in vivo and rendered cells more
sensitive to the cytotoxic activities of the DR5 ligand
tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL) [40]. In addition, the latter study demonstrated
that 2ME2-induced apoptosis required activation of cas-
pase-8, caspase-9, and caspase-3 [40]. Another recent
study also showed induction of caspase-3 and apoptosis
in response to 2ME2 in gastric carcinoma cells [41]. These
observation established in other systems and cell types
suggest that 2ME2 could be an element of investigation in
order to determine how E2 might be involved in the
induction of caspase cleavage in rat endometrium and the
possibility that activation of caspases observed might not
be a direct action of E2.
Recent studies demonstrated that the transcriptional
nuclear factor kappa-B (NF-κB) is a direct downstream tar-
get of phosphorylated Akt [42]. NF-κB is sequestered (p65
and p50 subunits) in the cytoplasm by the IκBs inhibitors
which are phosphorylation targets of Akt. Upon
phosphorylation IκBs are released and degradated
through ubiquitination and NF-κB enter nucleus for gene
expression [43]. In the literature, we found that XIAP pro-
moter is a target for NF-κB [27,28]. Since we have recently
demonstrated the activation of Akt in response to 17β-
estradiol in rat endometrium and that Akt has been
shown to activate NF-κB signaling pathway [42], we
wanted to know if Akt/ NF-κB/IκB pathway might be
involved in the regulation of XIAP expression. Results of
the present study showed that there was no difference in
the expression of NF-κB and IκB nor IκB phosphorylation
during the four stages of estrous cycle which exclude the
involvement of this pathway in the regulation of XIAP or
Smac/DIABLO expression. Other pathways downstream
of Akt known to be regulated by this kinase are currently
investigated in our laboratory such as eNOS [44,45], Bad
[46], glycogen synthase kinase 3β (GSK-3β) [47,48], and
caspase-9 [49]. A recent report further demonstrated that
insulin-like growth factor-1 (IGF-1) induced activation of
Akt, NF-κB and induced phosphorylation of Forkhead
transcription factor (FKHR), which in turn up-regulated a
series of intracellular anti-apoptotic proteins such as XIAP
[50]. Because, FKHR is also a well known target for Akt
action [51], phosphorylation, activity and regulation of
this transcription factor in the uterus needs to be
investigated.
In conclusion, the present study showed for the first time
the presence and regulation of XIAP and Smac/DIABLO in
the rat endometrium and further demonstrated that these
two survival factors are regulated in the opposite direction
by E2. Further analysis will be necessary to determine
more specifically, the intra-cellular and molecular signal
transducers involved in the process of apoptosis in the rat
reproductive tract and to determine the mechanism by
which XIAP and Smac/DIABLO are regulated.
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